199 related articles for article (PubMed ID: 24086533)
1. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
Kim GJ; Kim H; Park YN
PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
[TBL] [Abstract][Full Text] [Related]
2. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
3. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
4. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
5. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.
Ogasawara S; Akiba J; Nakayama M; Nakashima O; Torimura T; Yano H
J Gastroenterol Hepatol; 2015 Feb; 30(2):413-20. PubMed ID: 25087473
[TBL] [Abstract][Full Text] [Related]
7. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
Kim H; Park YN
Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
[TBL] [Abstract][Full Text] [Related]
10. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.
Fatourou E; Koskinas J; Karandrea D; Palaiologou M; Syminelaki T; Karanikolas M; Felekouras E; Antoniou E; Manesis EK; Delladetsima J; Tiniakos D
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1094-102. PubMed ID: 26011233
[TBL] [Abstract][Full Text] [Related]
11. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
Zen Y; Vara R; Portmann B; Hadzic N
Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.
Wang A; Wu L; Lin J; Han L; Bian J; Wu Y; Robson SC; Xue L; Ge Y; Sang X; Wang W; Zhao H
Nat Commun; 2018 Mar; 9(1):894. PubMed ID: 29497050
[TBL] [Abstract][Full Text] [Related]
14. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
[TBL] [Abstract][Full Text] [Related]
15. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
Chan AW; Tong JH; Chan SL; Lai PB; To KF
Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
[TBL] [Abstract][Full Text] [Related]
16. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
18. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
[TBL] [Abstract][Full Text] [Related]
19. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
[TBL] [Abstract][Full Text] [Related]
20. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
